Delivery Order SPE2DR25D2014-SPE2DR26FA3P9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,048.85 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $12,111.69 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a completion deadline of January 22, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 21, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,985.64 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30 mg) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,930.88 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30mg) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,676.98 for Adderall 30mg tablets (100 count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) on January 22, 2026, with a ceiling value of $1,074.15 and ultimate completion date of January 23, 2026. This competitively awarded, non-set-aside contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $4,633.50 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract. The award was made on December 22, 2025, with an ultimate completion date of December 23, 2025, and represents a non-set-aside, competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,838.49 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count) with a completion date of December 1, 2025. This competitive award, made on November 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Adderall 10 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $9,850.72 with a firm fixed price structure and an ultimate completion date of January 6, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA3P9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,289.81 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) on January 26, 2026, with an ultimate completion date of January 27, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The prime IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA awards such delivery orders to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/25/26 |